HADS-A ≤ 6 (%), n = 60 (61) | HADS-A > 6 (%), n = 38 (39) | P value | |
---|---|---|---|
Follow-up median in months (IQR) | 55 (33-69) | 59 (51-69) | .221a |
Bleeding | 1 (2) | 1 (3) | 1.0b |
Infection | 1 (2) | 1 (3) | 1.0b |
Hoarseness | 13 (22) | 13 (34) | .240b |
Dysphagia | 1 (2) | 1 (3) | 1.0b |
Cranial nerve injuries | 5 (8) | 5 (13) | .504b |
Recurrent laryngeal nerve palsy, transient | 2 (3), 2 (100) | 5 (13), 4 (80) | .105b |
Hypoglossal nerve palsy, transient | 3 (5), 2 (67) | 0 | .280b |
Stroke | 0 | 4 (11) | .020b |
Minor stroke (modified Rankin score 0-1) | 4 (100) | ||
Myocardial infarction | 0 | 0 | 1.0b |
30-day mortality | 0 | 0 | 1.0b |
Overall mortality | 9 (15) | 3 (8) | .27b |
Lost to follow-up | 4 (7) | 1 (3) | .381b |